The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: A 2-year open randomized controlled multicenter trial

Journal of Bone and Mineral Research

Volumn 17, Issue 6, 2002, Pages 1081-1094

  Bex, Marie ^a   Abs, Roger ^b   Maiter, Dominique ^c   Beckers, Albert ^d   Lamberigts, Gerard ^e   Bouillon, Roger ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e Algemeen Ziekenhuis St Jan   (Belgium)

Author keywords

Adult; Bone density; Controlled study; Growth hormone deficiency; Growth hormone therapy

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; AGED; BLOOD; BONE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; ONSET AGE; PATIENT COMPLIANCE; RADIODENSITOMETRY;

ADULT; AGE OF ONSET; AGED; BONE AND BONES; BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; GROWTH HORMONE; HUMAN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGE; PATIENT COMPLIANCE; SUPPORT, NON-U.S. GOV'T; HUMANS; MIDDLE AGED;

EID: 0035999443     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.6.1081     Document Type: Article

References (52)

1. Clinical review 61: Effects of growth hormone on human bone biology
2. Growth hormone and bone
3. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review
4. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males
5. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency
6. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency
7. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or longterm GH replacement therapy
8. Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults
9. Four years of growth hormone replacement in adults with growth hormone deficiency: Further increase in bone mineral density
10. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency
11. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults
12. Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency
13. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial
14. Universal standardization for dual X-ray absorptiometry: Patient and phantom cross-calibration results
15. The diagnosis of osteoporosis
16. Quantitative radiology: Radiogrammetry of cortical bone
17. Age-, sex-, and menopause-related changes of vertebral and peripheral bone: Population study using dual and single photon absorptiometry and radiogrammetry
18. Development of a questionnaire to assess the quality of life of adults with growth hormone deficiency
19. Time-related increase of biochemical markers of bone turnover in androgen-deficient male rats
20. Determination of serum creatinine by a direct colorimetric method
21. Homologous radioimmunoassay of human osteocalcin
22. Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies
23. A radioimmunoassay for 1, 25-dihydroxycholecalciferol
24. Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin
25. Linear mixed models for longitudinal data
26. A simple sequentially rejective Bonferonni test procedure
27. Reduced bone mineral content in adult patients with growth hormone deficiency
28. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism
29. Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency
30. Reduced bone mineral density in patients with adult onset growth hormone deficiency
31. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults
32. Growth hormone treatment in adults with adult-onset growth hormone deficiency increases iliac crest trabecular bone turnover: A 1-year, double-blind, randomized, placebo-controlled study
33. Elderly patients with adult-onset growth hormone deficiency are not osteopenic
34. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease
35. Treatment of postmenopausal osteoporosis
36. Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: Need for additional growth hormone substitution?
37. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency
38. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density
39. Diagnosis of growth-hormone deficiency in adults
40. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment
41. A low starting dose of genotropin in growth hormone-deficient adults
42. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease
43. New approach to the diagnosis of growth hormone deficiency in adults
44. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women
45. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: Role of sex hormone replacement
46. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults
47. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults
48. Metabolic aspects of acromegaly and its treatment
49. The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men
50. Effects of testosterone replacement in hypogonadal men
51. Withdrawal of long-term physiological growth hormone (GH) administration: Differential effects on bone density and body composition in men with adult-onset GH deficiency
52. Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: Results of a double-blind placebo-controlled study with open follow-up